Lithospermoside (Standard)
Lithospermoside (Griffonin) (Standard) is the analytical standard of Lithospermoside (HY-N0821). This product is intended for research and analytical applications. Lithospermoside is an orally active Na+/K+-ATPase inhibitor and hypoglycemic agent. Lithospermoside increases intracellular sodium levels in normal and sickle red blood cells. Lithospermoside reduces fasting blood glucose levels, improves glucose tolerance, and prevents weight loss in diabetic mice. Lithospermoside can be used in the research of sickle cell disease and diabetes.
For research use only. We do not sell to patients.
- CAS No.: 63492-69-3
- Formula: C14H19NO8
- Molecular Weight:329.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 63492-69-3
-
Molecular Weight 329.30
-
Formula C14H19NO8
-
SMILES
O[C@@H]1[C@@](/C(C=C[C@H]1O)=C\C#N)([H])O[C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO
-
Synonyms
Griffonin (Standard)
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Lithospermoside (Standard)
- 63492-69-3
- Griffonin (Standard)
- Reference Standards
- Na+/K+ ATPase
- diabetes mellitus
- sickle cell disease
- Na+,K+-ATPase
- human sickle cell patients
- diabetic mice
- normal human subjects
- Bauhinia holophylla
- erythrocytes
- streptozotocin-induced diabetic mice
- sickle erythrocytes
- Inhibitor
- inhibitor
- inhibit